BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 84 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 16.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,530 | +65452.8% | 17,000 | -16.7% | 0.00% | – |
| Q2 2023 | $521 | -99.9% | 20,400 | -3.3% | 0.00% | -100.0% |
| Q1 2023 | $448,797 | -0.2% | 21,100 | +38.8% | 0.00% | 0.0% |
| Q4 2022 | $449,920 | +27.1% | 15,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $354,000 | -75.0% | 15,200 | -82.0% | 0.00% | 0.0% |
| Q2 2022 | $1,417,000 | – | 84,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 968,671 | $24,720,484 | 6.29% |
| Paradigm Biocapital Advisors LP | 1,985,430 | $50,668,174 | 3.92% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $32,712,046 | 3.54% |
| First Light Asset Management, LLC | 1,739,449 | $44,390,738 | 3.48% |
| Deep Track Capital, LP | 2,819,045 | $71,942,028 | 3.33% |
| Logos Global Management LP | 520,000 | $13,270,400 | 1.80% |
| Soleus Capital Management, L.P. | 411,800 | $10,509,136 | 1.17% |
| HighVista Strategies LLC | 92,434 | $2,358,916 | 1.08% |
| DAFNA Capital Management LLC | 122,200 | $3,118,544 | 0.85% |
| Ikarian Capital, LLC | 203,037 | $5,181,504 | 0.82% |